メイン州における転移性癌の臨床試験
メイン州内の拠点で、転移性癌に関する9件の研究が参加者を募集しています。
メイン州内の都市
公式研究テキスト（英語）
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Harold Alfond Center for Cancer Care, Augusta
- Lafayette Family Cancer Center-EMMC, Brewer
- MaineHealth Maine Medical Center- Scarborough, Scarborough
- 他1件
被験者募集中第2相
全年齢 · 全性別 · 2026/10/02更新 · NCT05564377Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- New England Cancer Specialists, Topsham
- New England Cancer Specialists, Westbrook
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07222800A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Maine Medical Center, Scarborough
被験者募集中第1/2相
25歳以下 · 全性別 · 2026/09/25更新 · NCT04094610A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- New England Cancer Specialists, Westbrook
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07174336A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
- Maine Medical Center - Scarborough Campus, Scarborough
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07213804AMG 436 as Monotherapy and Combination Therapy in Participants With MSI-H/dMMR Solid Tumors
- New England Cancer Specialists, Westbrook
被験者募集中第1相
18歳〜99歳 · 全性別 · 2026/09/21更新 · NCT07403721Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Scarborough
被験者募集中第3相
18歳以上 · 女性 · 2026/07/29更新 · NCT07044336A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- MaineHealth Institute for Research, South Portland
被験者募集中第3相
18歳以上 · 全性別 · 2026/04/09更新 · NCT06064877SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Scarborough
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。